Get all your news in one place.
100's of premium titles.
One app.
Start reading
Kiplinger
Kiplinger
Business
Joey Solitro

Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know

A blood sugar measurement tool on top of chart measuring blood sugar levels.

Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year revenue forecast.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.